Navigation Links
SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients
Date:11/7/2007

cular death, MI or stroke. Patients will be followed for a minimum of one year. This Phase III trial is being conducted by the Thrombolysis in Myocardial Infarction (TIMI) Study Group.

The Phase III Thrombin Receptor Antagonist Clinical Event Reduction in acute coronary syndrome (TRA-CER) trial is a multinational, randomized, double-blind, placebo-controlled study in approximately 10,000 patients with non-ST-segment elevation acute coronary syndrome. Patients will be randomized to either placebo plus standard medical care (including aspirin or clopidogrel) or to TRA plus standard medical care. The Phase III TRA-CER trial will use the oral 40 mg loading dose and the 2.5 mg maintenance dose. In the Phase II TRA-PCI trial, this dose was not statistically different from placebo in the combination of TIMI Major and Minor bleeding, and although not statistically significant, resulted in the greatest reduction in major adverse cardiac events, predominately periprocedural myocardial infarctions.

The primary endpoint of the Phase III TRA-CER trial is the composite of cardiovascular death, MI, rehospitalization for ACS, urgent coronary revascularization or stroke. The key secondary endpoint is the composite of cardiovascular death, MI or stroke. Patients will be followed for a minimum of one year. This Phase III trial is being conducted by the Duke Clinical Research Institute, Durham, NC.

These Phase III trials follow the results of two Japanese Phase II trials in ACS patients and in patients with previous ischemic events that further documented the lack of incremental bleeding with the use of TRA plus standard of care, and, for the first time, reported a statistically significant reduction in cardiovascular events, specifically periprocedural myocardial infarction (MI) in the ACS patients undergoing PCI.

About the Thrombin Receptor Antagonist

The investigational antiplatelet TRA is being developed by Schering-Plough for the prevention and treatm
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Novel Technology Breaks Through Cancer Pain
2. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
3. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
4. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)...  The annual customer satisfaction survey of over 5,700 ... #1 across all specialties. Every year, Florida ... poll of EHR users and publishes an internationally recognized ... Praxis EMR topped 348 other systems, with the ... used by Black Book. In addition to earning the ...
(Date:5/29/2015)... MISSISSAUGA, ON , May 29, 2015 /CNW/ ... COV), an advanced medical technologies company, is delighted ... quarter ended March 31, 2015, which includes revenue ... for the quarter of $264,340. Revenue from advanced wound ... ended March 31, 2015 increased 24% to $1,742,672 ...
(Date:5/29/2015)... , May 29, 2015 Amgen (NASDAQ: ... two pivotal Phase 3, global, randomized, placebo-controlled trials ... treatment of secondary hyperparathyroidism (SHPT) in patients with ... met the primary endpoint, demonstrating that a greater ... achieved a greater than 30 percent reduction in ...
Breaking Medicine Technology:Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7
... 2011 Watson Pharmaceuticals, Inc. (NYSE: ... Laboratories, Inc. – Florida, filed an Abbreviated New ... Drug Administration (FDA) seeking approval to market Dutasteride ... a generic version of GlaxoSmithKline,s AVODART(R), which is ...
... 20, 2011 The Consumer Healthcare Products Association ... Texas Governor Rick Perry signing into law legislation ... citizens to access common cold and allergy medicines ... the legal limit: "We applaud the ...
Cached Medicine Technology:Watson Confirms AVODART(R) Patent Challenge 2
(Date:5/29/2015)... RIDGELAND, Miss. (PRWEB) May 29, 2015 ... recently announced the graduates of its Advanced Training ... trains students, who fill roles in their health ... both the theory and methodology of continuous quality ... is a sister-program to Dr. Brent James’ internationally ...
(Date:5/29/2015)... York, New York (PRWEB) May 29, 2015 ... distributor of patented products, announces that it has signed ... Room, a technology patent that aims to let people ... industry experts in real time. , "This is an ... Chat Room " said Scott J. Cooper, CEO and ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Inspire Nexus, ... created a solution to the question many life coaches ... gain the experience and hours necessary to become a ... pondered this question, but not for long. Inspire Nexus, ... to hire Coaches directly. Coaches who have experience coaching ...
(Date:5/29/2015)... has joined forces with Raw Elements Physical Eco Protection ... sun protection. The print component of “Skin Health” is ... 250,000 copies and an estimated readership of 750,000 readers. ... social media strategy, and across a network of top ... version of the campaign, click here . ...
(Date:5/29/2015)... 29, 2015 The campaign focuses on ... a number of specific concerns within, including the importance ... mental health in the workplace. We are encouraged to ... campaign also brings special focus to people living with ... up and seek help from healthcare professionals and their ...
Breaking Medicine News(10 mins):Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2
... early tooth decay, study finds , , FRIDAY, July 4 (HealthDay ... vitamin D during pregnancy may be at increased risk for ... study finds. , Researchers at the University of Manitoba analyzed ... trimester of pregnancy and found only 21 (10.5 percent) of ...
... Canada Low maternal vitamin D levels during ... defects, which are a risk factor for early-childhood ... of the,International Association for Dental Research, investigators from ... results of a study they conducted to determine ...
... (BUSM) and Boston Medical Center (BMC) found that patients ... of any type did not experience serious harm. However, ... obstetrics/gynecology setting received the most benefit. The findings, which ... , also conclude that disclosures made in an emergency ...
... Grubb & Ellis Healthcare,REIT, Inc. today announced it ... the addition of two skilled nursing facilities in,California. The ... four in Texas, the acquisition of which closed in ... El Monte and 1955 Lomita Blvd., in,Lomita, each of ...
... July 3 The Minnesota Nurses,Association (MNA) announced ... for U.S. House of Representatives, Congressional District 6., ... he shares a guiding principle,important to Minnesota nurses: ... ability to obtain healthcare," said MNA Political Committee,Chair, ...
... Hachinski has been named to the Order of Canada, ... the field of neurology. , Hachinski is a "Distinguished ... the Department of Clinical Neurological Sciences at the Schulich ... founding and current chairman of the International Society for ...
Cached Medicine News:Health News:Disclosing violence to primary care or obestetrics/gynecology physicians most beneficial 2Health News:Grubb & Ellis Healthcare REIT Acquires Senior Care Portfolio 1 in Calif. 2Health News:Grubb & Ellis Healthcare REIT Acquires Senior Care Portfolio 1 in Calif. 3Health News:Minnesota Nurses Association Endorses Elwyn Tinklenberg for Congress 2Health News:Pioneering stroke researcher awarded Canada's highest honor 2
Sighting and visualization system of the digital operating suite. The platform that links navigation, and intra-operative imaging to form the ultimate surgical workstation....
... OME-8000 represents the finest integration ... expertise in optics, digital imaging, ... a surgical microscope. The surgical ... gives the surgeon an unprecedented ...
The Leica MS1 F/MC1 F is designed to mount on the ceiling with a high degree of mobility. Its unique and patented suspension concept assures a superior stability and a perfect and steady microscope i...
Galilean Loupes...
Medicine Products: